This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|October 1, 2011
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-10-01-2011
- Volume 23
- Issue 10
Time Is Of The Essence
Author(s)Control, a senior compliance officer
Giving contamination time to build up can cause headaches for more than just your company.
Advertisement
Giving contamination time to build up can cause headaches for more than just your company.
This article was also published in our US sister publication Pharmaceutical Technology and can be read
Articles in this issue
almost 15 years ago
Overcoming The Distancealmost 15 years ago
Novel Excipients: A Rare Speciesalmost 15 years ago
Standing Out In The Outsourcing Crowdalmost 15 years ago
Why Good Records Management Is Keyalmost 15 years ago
Europe Edging Towards Electronic Prescribingalmost 15 years ago
EU Market Challengesalmost 15 years ago
Challenges In The Changing Outsourcing Landscapealmost 15 years ago
Taking It For Grantedalmost 15 years ago
Newsalmost 15 years ago
Trends and Challenges in Biologics OutsourcingAdvertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement